Avantax Planning Partners, Inc. Abbott Laboratories Transaction History

Avantax Planning Partners, Inc.

$2.78 Billion
Q3 2024

A detailed history of Avantax Planning Partners, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Avantax Planning Partners, Inc. holds 24,354 shares of ABT stock, worth $2.87 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

24,354

Previous 26,304 7.41%

Holding current value

$2.87 Million

Previous $2.73 Million 1.57%

% of portfolio

0.1%

Previous 0.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $195,136 - $230,353	-1,950 Reduced 7.41%	24,354 $2.78 Million
Q2 2024 Aug 09, 2024	SELL	$100.73 - $112.44 $146,058 - $163,038	-1,450 Reduced 5.22%	26,304 $2.73 Million
Q1 2024 May 02, 2024	BUY	$109.52 - $120.96 $715,056 - $789,747	6,529 Added 30.76%	27,754 $3.15 Million
Q4 2023 Feb 09, 2024	BUY	$90.19 - $110.4 $541 - $662	6 Added 0.03%	21,225 $2.34 Million
Q3 2023 Nov 03, 2023	SELL	$95.53 - $114.62 $490,355 - $588,344	-5,133 Reduced 19.48%	21,219 $2.06 Million
Q2 2023 Jul 17, 2023	SELL	$100.78 - $112.29 $48,172 - $53,674	-478 Reduced 1.78%	26,352 $2.87 Million
Q1 2023 Apr 20, 2023	SELL	$96.86 - $114.01 $7,167 - $8,436	-74 Reduced 0.28%	26,830 $2.72 Million
Q4 2022 Feb 09, 2023	SELL	$95.06 - $111.52 $377,293 - $442,622	-3,969 Reduced 12.86%	26,904 $2.95 Million
Q3 2022 Oct 14, 2022	SELL	$96.76 - $112.03 $8,998 - $10,418	-93 Reduced 0.3%	30,873 $2.99 Million
Q2 2022 Jul 18, 2022	SELL	$102.07 - $123.37 $27,150 - $32,816	-266 Reduced 0.85%	30,966 $3.36 Million
Q1 2022 May 09, 2022	SELL	$114.02 - $139.04 $16,418 - $20,021	-144 Reduced 0.46%	31,232 $3.7 Million
Q4 2021 Jan 28, 2022	BUY	$115.53 - $141.46 $138,173 - $169,186	1,196 Added 3.96%	31,376 $4.42 Million
Q3 2021 Oct 27, 2021	BUY	$116.66 - $129.06 $53,896 - $59,625	462 Added 1.55%	30,180 $3.57 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $470,977 - $554,407	4,452 Added 17.62%	29,718 $3.45 Million
Q1 2021 May 06, 2021	BUY	$108.84 - $128.23 $36,134 - $42,572	332 Added 1.33%	25,266 $3.03 Million
Q4 2020 Feb 04, 2021	SELL	$105.0 - $114.42 $189,525 - $206,528	-1,805 Reduced 6.75%	24,934 $2.73 Million
Q3 2020 Oct 28, 2020	SELL	$91.64 - $111.29 $162,477 - $197,317	-1,773 Reduced 6.22%	26,739 $2.91 Million
Q2 2020 Jul 15, 2020	SELL	$76.57 - $98.0 $122,971 - $157,388	-1,606 Reduced 5.33%	28,512 $2.61 Million
Q1 2020 Apr 27, 2020	BUY	$62.82 - $91.86 $169,676 - $248,113	2,701 Added 9.85%	30,118 $2.38 Million
Q4 2019 Jan 15, 2020	BUY	$78.51 - $87.4 $1,884 - $2,097	24 Added 0.09%	27,417 $2.38 Million
Q3 2019 Nov 08, 2019	BUY	$81.84 - $88.74 $59,906 - $64,957	732 Added 2.75%	27,393 $2.29 Million
Q2 2019 Aug 07, 2019	SELL	$72.88 - $85.0 $9,838 - $11,475	-135 Reduced 0.5%	26,661 $2.27 Million
Q1 2019 May 08, 2019	BUY	$66.22 - $80.06 $301,632 - $364,673	4,555 Added 20.48%	26,796 $2.14 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $71,132 - $80,582	-1,085 Reduced 4.65%	22,241 $1.61 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $49,438 - $59,641	813 Added 3.61%	23,326 $1.71 Million
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $106,446 - $117,485	-1,849 Reduced 7.59%	22,513 $1.37 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $36,969 - $41,798	657 Added 2.77%	24,362 $1.46 Million
Q4 2017 Feb 09, 2018	SELL	$53.68 - $57.47 $288,207 - $308,556	-5,369 Reduced 18.47%	23,705 $1.35 Million
Q3 2017 Oct 19, 2017	BUY	$48.06 - $53.64 $1.4 Million - $1.56 Million	29,074	29,074 $1.55 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Planning Partners, Inc. with notifications on news.

Account

Avantax Planning Partners, Inc. Abbott Laboratories Transaction History